# Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk

> **NCT00017134** · NA · TERMINATED · sponsor: **Gynecologic Oncology Group** · enrollment: 71 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** fenretinide
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00017134
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 71 (ESTIMATED)
- **Why stopped:** Withdrawn due to poor accrual
- **Last updated:** 2013-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017134, "Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00017134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*